It is my great pleasure, as Chair, to invite you to join us for the symposium
‘rpFVIII in Acquired Haemophilia A: Real-World Experience’.
Our Faculty of expert clinicians will reﬂ ect on the current management of Acquired Haemophilia A and consider the published clinical evidence and real life clinical experience of rpFVIII. Through illustrative case studies, our Faculty will share practical insights into the clinical use of rpFVIII from the USA and Europe.
Charles Hay, Consultant Haematologist from Manchester Royal Inﬁ rmary in the UK, will Co-Chair the symposium with me and your faculty who will lead us through this engaging programme are:
We look forward to seeing you there.
Senior Medical Director, Global Medical Affairs Hematology, Shire
|13:15-13:25||Welcome: the challenges of AHA||Alessandro Gringeri (Co-Chair)|
|13:25-13:40||rpFVIII: what the clinical evidence tells us||Charles Hay, UK (Co-Chair)|
|13:40-14:20||rpFVIII: sharing experience from US & EU clinical practice||Alice Ma, USA
Christian Langer, Germany
|14:20-14:30||Q&A/Panel Discussion||Facilitated by Alessandro Gringeri & Charles Hay|